KCNQ2 Antibodies

Santa Cruz Biotechnology features a diverse variety of KCNQ2 monoclonal antibodies for research focused on understanding KCNQ2 protein function. KCNQ2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KCNQ2 is a critical component of the potassium ion channel family, playing a vital role in regulating neuronal excitability and maintaining the resting membrane potential. Mutations in the KCNQ2 gene are associated with various neurological disorders, including benign familial neonatal seizures and other forms of epilepsy. Understanding the function and regulation of KCNQ2 is essential for developing targeted therapies for these conditions. KCNQ2 monoclonal antibodies enable precise detection and analysis of KCNQ2 expression patterns in various cellular environments. Researchers can investigate KCNQ2's role in neurotransmitter release, action potential generation, and cellular signaling pathways. Advanced research with KCNQ2 monoclonal antibodies contributes to expanding knowledge of neurological disorders and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing understanding of KCNQ2's role in neurological health and disease development.